Douglas Hendren serves as Executive at IRIS BIOTECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, Douglas Hendren has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 5, 2015 involved exercising options for 3.47 shares valued at $3.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 5, 2015 | IRSB | $3 | Conversion | 3.47 | $1.00 | Discretionary |
Douglas Hendren currently holds 188,032 shares of IRIS BIOTECHNOLOGIES INC (IRSB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Hendren has been a net neutral trader of IRSB stock. They have purchased $0 and sold $0 worth of shares.
Douglas Hendren's most recent insider trade was on May 5, 2015, when they sold 3.47 shares at $1.00 per share.
Get notified when new Form 4 filings are submitted